Cns Pharmaceuticals Inc (CNSP) Stock Analysis

Cns Pharmaceuticals Inc (CNSP) is a publicly traded company in the HEALTHCARE sector. It trades at $4.92, carries a market capitalization of $7.35M. This page summarizes the public market data, fundamentals, and frequently asked questions for CNSP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Cns Pharmaceuticals Inc currently has a Neutral sentiment score of -0.06.

About Cns Pharmaceuticals Inc

CNS Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Houston, Texas, dedicated to innovating therapies for brain and central nervous system tumors. The company is advancing its lead developmental candidate, which targets significant unmet medical needs in oncology, particularly in neuro-oncology. Leveraging a strong scientific foundation and strategic collaborations, CNS Pharmaceuticals is committed to improving patient outcomes and addressing the critical ...

GNG Research Analysis

GNG Research scores Cns Pharmaceuticals Inc (CNSP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CNSP.

Frequently Asked Questions

Does CNSP pay dividends?

Cns Pharmaceuticals Inc (CNSP) does not currently pay a regular dividend.

What is CNSP's market cap?

Cns Pharmaceuticals Inc (CNSP) has a market capitalization of $7.35M with a current stock price of $4.92.